Cargando…

Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?

Atrial fibrillation is frequently diagnosed in patients with liver cirrhosis, especially in those with non-alcoholic steatohepatitis or alcoholic etiology. Anticoagulant treatment is recommended for thromboembolic protection in patients with atrial fibrillation. Considering the impaired coagulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gîrleanu, Irina, Trifan, Anca, Huiban, Laura, Muzica, Cristina Maria, Petrea, Oana Cristina, Sîngeap, Ana-Maria, Cojocariu, Camelia, Chiriac, Stefan, Cuciureanu, Tudor, Stafie, Remus, Zenovia, Sebastian, Stratina, Ermina, Rotaru, Adrian, Nastasa, Robert, Sfarti, Catalin, Costache, Irina Iuliana, Stanciu, Carol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047341/ https://www.ncbi.nlm.nih.gov/pubmed/36980468 http://dx.doi.org/10.3390/diagnostics13061160

Ejemplares similares

Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter
por: Trifan, Anca, et al.
Publicado: (2022)

Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
por: Trifan, Anca, et al.
Publicado: (2022)

Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response
por: Trifan, Anca, et al.
Publicado: (2022)

Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter
por: Trifan, Anca, et al.
Publicado: (2022)

High prevalence of liver fibrosis among general population: a Romanian population-based study
por: Trifan, Anca, et al.
Publicado: (2023)

Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis
por: Trifan, Anca, et al.
Publicado: (2022)

Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
por: Chiriac, Stefan, et al.
Publicado: (2023)

The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure
por: Igna, Razvan, et al.
Publicado: (2022)

The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy
por: Igna, Razvan, et al.
Publicado: (2022)

Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
por: Trifan, Anca, et al.
Publicado: (2023)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
por: Singeap, Ana-Maria, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
por: Chiriac, Stefan, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
por: Muzica, Cristina M., et al.
Publicado: (2020)

The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students
por: Nastasa, Robert, et al.
Publicado: (2021)

Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury
por: Gîrleanu, Irina, et al.
Publicado: (2022)

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
por: Zenovia, Sebastian, et al.
Publicado: (2021)

Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania—A Population-Based Screening—The First Step to Viral Micro-Elimination
por: Huiban, Laura, et al.
Publicado: (2021)

The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort
por: Girleanu, Irina, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease
por: Cojocariu, Camelia, et al.
Publicado: (2020)

Did the severe acute respiratory syndrome-coronavirus 2 pandemic cause an endemic Clostridium difficile infection?
por: Cojocariu, Camelia, et al.
Publicado: (2021)

The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania
por: Chiriac, Stefan, et al.
Publicado: (2021)

Clinical Impact of Small Bowel Capsule Endoscopy in Obscure Gastrointestinal Bleeding
por: Singeap, Ana-Maria, et al.
Publicado: (2020)

Idiopathic Cervical Esophageal Webs: A Case Report and Literature Review
por: Petrea, Oana Cristina, et al.
Publicado: (2020)

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
por: Muzica, Cristina Maria, et al.
Publicado: (2020)

Role of ammonia in predicting the outcome of patients with acute-on-chronic liver failure
por: Chiriac, Stefan, et al.
Publicado: (2021)

L3 Skeletal Muscle Index Dynamics in Patients with HCV-Related Compensated Cirrhosis Following Sustained Virological Response after Direct Acting Antiviral Treatment
por: Mihai, Florin, et al.
Publicado: (2021)

The Relation between Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Different Cannulation Techniques: The Experience of a High-Volume Center from North-Eastern Romania
por: Chiriac, Stefan, et al.
Publicado: (2023)

Systemic Oxidative Stress Markers in Cirrhotic Patients with Hepatic Encephalopathy: Possible Connections with Systemic Ammoniemia
por: Sfarti, Cătălin, et al.
Publicado: (2020)

Portal vein thrombosis in cirrhotic patients - it is always the small pieces that make the big picture
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Natural Course of Nonmalignant Partial Portal Vein Thrombosis in Cirrhotic Patients
por: Girleanu, Irina, et al.
Publicado: (2014)

Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
por: Robea, Madalina Andreea, et al.
Publicado: (2023)

Ulcerated intussuscepted jejunal lipoma-uncommon cause of obscure gastrointestinal bleeding: A case report
por: Cuciureanu, Tudor, et al.
Publicado: (2019)

Chronic hepatitis C virus infection: a new modifiable cardio-metabolic risk factor?
por: CUCIUREANU, TUDOR, et al.
Publicado: (2017)

Liver Remodeling on CT Examination in Patients with HCV Compensated Cirrhosis Who Achieved Sustained Virological Response after Direct-Acting Antivirals Treatment
por: Mihai, Florin, et al.
Publicado: (2020)

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017)

Splanchnic Vein Thrombosis in Cirrhosis − Areas Still in the Shadow
por: Gîrleanu, Irina, et al.
Publicado: (2018)

Be bold, be brave, but above all be brief
Publicado: (1969)

The Professional and Psycho-Emotional Impact of the COVID-19 Pandemic on Medical Care—A Romanian GPs’ Perspective
por: Stafie, Celina Silvia, et al.
Publicado: (2021)

Increased liver stiffness in extrahepatic cholestasis caused by choledocholithiasis
por: Trifan, Anca, et al.
Publicado: (2011)

Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
por: Trifan, Anca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b21l2o8aoa11p6vqjb29ebdb7d